Further comparative analysis of TUBA1B expression levels across tumor tissues showed that glioblastoma multiforme (GBM) had the highest expression, while hepatocellular carcinoma (LIHC) exhibited the lowest (Figure 1B). This evidence concerns the gene TUBA1B and hepatocellular carcinoma.